Loading clinical trials...
Loading clinical trials...
Randomized, Comparative, Double Blind Controlled Phase II Clinical Trial, to Evaluate the Efficacy of ApE in Patients With Multiple Sclerosis (MS).
Conditions
Interventions
1 - Andrographis paniculata p/st extract
2 - Excipients
Locations
1
Chile
Hospital Regional
Valdivia, Los Ríos Region, Chile
Start Date
January 1, 2012
Primary Completion Date
February 1, 2015
Completion Date
May 1, 2015
Last Updated
June 23, 2016
NCT05359653
NCT06390930
NCT03401879
NCT06389968
NCT05834855
NCT06413602
Lead Sponsor
Universidad Austral de Chile
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions